查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1132105

疼痛管理药物全球市场需求和管道洞察力——药物类型、给药途径、最终用途、可用性、销售渠道、地区、国家分析、COVID-19 影响、预测

Global Pain Management Drugs Market Demand and Pipeline Insights - Analysis By Drug Type, Route of Administration, End-Use, Availability, Sales Channel, By Region, By Country: Market Insights & Forecast with Impact of COVID-19
出版日期: | 出版商: Azoth Analytics | 英文 280 Pages | 订单完成后即时交付

价格

到 2021 年，全球疼痛管理市场价值将达到 8212 万美元，其中美洲在区域市场份额中处于领先地位。市场受到慢性疼痛状况增加和全球癌症疼痛流行的推动。此外，一些新兴国家的人口老龄化正在增加，预计这将推动市场增长。

此外，美国、日本和中国等主要国家的各种医疗改革提高了预期寿命。预计这将增加对许多疼痛管理药物的需求，例如晚期癌症、慢性疼痛和术后疼痛管理药物。

本报告研究了全球疼痛管理市场，并提供了诸如市场规模和预测、市场动态、按细分市场/地区划分的市场分析、竞争格局和主要参与者概况等信息。

内容

第1章研究范围与研究方法

  • 调查范围
  • 调查方法
  • 执行摘要

第 2 章战略建议

第 3 章全球疼痛管理市场：产品概述

第 4 章全球疼痛管理市场：管道分析

  • 拥有疼痛管理药物管线的主要公司的竞争定位
  • 研究药物
    • Basimglurant (NOE-101)：药物描述和结果
  • 第一阶段
    • Resiniferatoxin (RTX)：药物描述和结果
    • VX-548：药物描述和结果
  • 二/三期
    • TLC590，布比卡因：药物描述和结果
  • 第二阶段
    • BAY2395840：药物描述和结果
    • Libvatrep-SAF312：药物描述和结果
    • 曲美替尼：药物描述和结果
    • Canakinumab +LNA043：药物描述和结果
    • Erenumab-aooe (EREN)：药物描述和结果
    • Erenumab-Aooe (Aimovig)：药物描述和结果
    • Erenumab-Aooe 70 MG：药物描述和结果
    • Botox（onabotulinum toxin A）：药物描述和结果
    • Resiniferatoxin：药物描述和结果
    • Resiniferatoxin，Zilretta：药物描述和结果
    • LY3526318：药物描述和结果
    • LY3526318：药物描述和结果
    • Quinagolide (FE 999051)：药物描述和结果
    • HMI-115：药物描述和结果
  • 第三阶段
    • 苏金单抗：药物描述和结果
    • Venglustat (GZ402671)：药物描述和结果
    • Elagolix + 雌二醇/醋酸炔诺酮：药物描述和结果
    • Elagolix + 复方口服避孕药 (COC)：药物描述和结果
    • 布洛芬 PR（300 毫克和 200 毫克）：药物描述和结果
    • 布洛芬液体胶囊（200 毫克）：药物描述和结果
    • 静脉 (IV) 曲马多 (AVE-901)：药物描述和结果
  • 第四阶段
    • Catapresan：药物描述和结果
    • Ubrogepant 50 MG、100 MG：药物描述和结果 Galcanezumab：药物描述和结果 Erenumab 预装注射器：药物描述和结果

第 5 章全球疼痛管理市场：分析

  • 评估全球疼痛管理市场的宏观经济指标
  • 疼痛管理药物市场
  • 市场规模（价值，2018-2028）
  • 全球疼痛管理市场：增长和预测
  • COVID-19 对全球疼痛管理药物市场的影响

第 6 章全球疼痛管理市场：按药物类型进行的细分分析

  • 按药物类型划分的全球疼痛管理药物市场细分
  • 疼痛管理药物市场竞争定位：按药物类型（2021 年、2028 年）
  • 对乙□氨基酚（价值，2018-2028）
  • 非甾体抗炎药（金钱，2018-2028）
  • 麻醉药（阿片类药物）（价值，2018-2028 年）
  • 其他（金额，2018-2028）

第 7 章全球疼痛管理市场：管理部门分析

  • 全球疼痛管理药物市场细分，按给药途径
  • 疼痛管理药物市场的竞争对手定位：按给药途径（2021 年、2028 年）
  • 本地（金钱，2018-2028）
  • 静脉注射（金钱，2018-2028）
  • 口头（金钱，2018-2028）
  • 其他（金额，2018-2028）

第 8 章全球疼痛管理市场：按最终用途划分的细分分析

  • 按最终用途划分的全球疼痛管理药物市场细分
  • 疼痛管理药物市场竞争对手定位：按最终用途分类（2021 年、2028 年）
  • 炎症（金钱，2018-2028）
  • 神经性疼痛（金钱，2018-2028）
  • 肌肉骨骼疼痛（金钱，2018-2028）
  • 严重和慢性疼痛（金钱，2018-2028）

第 9 章全球疼痛管理市场：可用性性别细分

  • 全球疼痛管理市场细分：按性别划分的可用性
  • 竞争对手在疼痛管理药物市场中的定位：按性别划分的可用性（2021 年、2028 年）
  • 处方（数量，2018-2028 年）
  • 场外交易 (OTC)（金额，2018-2028 年）

第 10 章全球疼痛管理市场：按销售渠道进行的细分分析

  • 按分销渠道划分的全球疼痛管理药物市场细分
  • 疼痛管理药物市场竞争对手定位：按销售渠道（2021 年、2028 年）
  • 医院药房（价值，2018-2028 年）
  • 零售药房（金额，2018-2028）
  • 电子商务（价值，2018-2028 年）

第 11 章全球疼痛管理市场：区域分析

  • 全球疼痛管理药物市场的竞争定位：按地区划分（2021 年、2028 年）

第 12 章。美国疼痛管理市场：分析 (2018-2028)

  • 评估美洲疼痛管理药物市场的宏观经济指标
  • 美国疼痛管理药物市场规模和预测（价值，2018-2028）
  • 北美和南美的疼痛管理药物市场
  • 美洲疼痛管理市场：主要参与者
  • 美洲疼痛管理市场：细分分析
  • 按药物类型细分市场
  • 按管理途径细分市场
  • 按最终用途细分市场
  • 市场细分：性别可用性
  • 按销售渠道细分市场
  • 北美和南美疼痛管理药物市场：按国家/地区分析
  • 美洲疼痛管理市场：机会图：按国家/地区分类（价值，2028 年）
  • 美洲疼痛管理药物市场的竞争定位：按国家/地区分类
  • 美国
  • 加拿大

第 13 章欧洲疼痛管理市场：分析 (2018-2028)

  • 评估欧洲疼痛管理市场的宏观经济指标
  • 欧洲疼痛管理药物市场规模和预测（价值，2018-2028）
  • 欧洲疼痛管理市场
  • 欧洲疼痛管理市场：主要参与者
  • 欧洲疼痛管理市场：细分分析
  • 按药物类型细分市场
  • 按管理途径细分市场
  • 按最终用途细分市场
  • 市场细分：性别可用性
  • 按销售渠道细分市场
  • 欧洲疼痛管理市场：国家/地区分析
  • 欧洲疼痛管理市场：机会图：按国家/地区分类（价值，2028 年）
  • 在欧洲疼痛管理市场中定位竞争对手：按国家/地区分类
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 意大利

第 14 章亚太疼痛管理市场：分析（2018-2028）

  • 亚太疼痛管理药物市场宏观经济指标评估
  • 亚太地区疼痛管理药物市场规模及预测（价值，2018-2028）
  • 亚太疼痛管理药物市场
  • 亚太疼痛管理药物市场：主要参与者
  • 亚太地区疼痛管理市场：细分分析
  • 按药物类型细分市场
  • 按管理途径细分市场
  • 按最终用途细分市场
  • 市场细分：性别可用性
  • 按销售渠道细分市场
  • 亚太地区疼痛管理市场：国家/地区分析
  • 亚太地区疼痛管理市场：机会图：按国家/地区分类（价值，2028 年）
  • 亚太地区疼痛管理药物市场的竞争定位：按国家/地区分类
  • 中国
  • 日本
  • 印度

第 15 章中东和非洲疼痛管理市场

  • 评估中东和非洲疼痛管理药物市场的宏观经济指标
  • 中东和非洲疼痛管理市场：规模和预测（2018-2028 年）
  • 按药物类型细分市场
  • 按管理途径细分市场
  • 按最终用途细分市场
  • 市场细分：性别可用性
  • 按销售渠道细分市场

第 16 章全球疼痛管理市场动态

  • 全球疼痛管理药物市场的驱动因素
  • 全球疼痛管理药物市场的製约因素
  • 全球疼痛管理药物市场趋势

第 17 章市场吸引力和战略分析

  • 世界疼痛管理药物市场吸引力图表 - 按药物类型（2028 年）
  • 世界疼痛管理药物市场吸引力图表 - 按给药途径（2028 年）
  • 世界疼痛管理药物市场吸引力图表 - 按最终用途分类（2028 年）
  • 世界疼痛管理药物市场吸引力图表 - 按性别划分的可用性（2028 年）
  • 世界疼痛管理药物市场吸引力图表 - 按销售渠道（2028 年）
  • 世界疼痛管理药物市场吸引力图表 - 按地区划分（2028 年）

第 18 章竞争格局

  • 世界领先公司的市场份额

第 19 章公司简介（业务描述、财务分析、业务战略）

  • Pfizer Inc.
  • Johnson & Johnson
  • GSK plc.
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Boehringer Ingelheim
  • AbbVie Inc.
  • Teva pharmaceuticals
  • Sanofi
  • Amgen

Executive Summary

According to Azoth Analytics research report published in September 2022, the global Pain Management Drugs market was valued at USD 82.12 million in the year 2021 with Americas leading the regional market share.

The global Pain Management Drugs Market is driven by an increasing number of Chronic Pain diseases and the prevalence of cancer pain worldwide. Additionally, a growing population in which the number of geriatric population is high in several developing countries is anticipated to propel the growth of the global Pain Management drugs market.

Additionally, life expectancy has increased due to various healthcare reforms in major economies such as the U.S., Japan, and China. This is likely to drive demand for many Pain Management drugs for advanced stages of cancer, chronic pain conditions and post-operative pain management drugs.

The COVID- 19 pandemic had a mixed impact on the Global Pain Management Drugs market by affecting the drug supply chain dramatically which led to hindrances in the production and sale of opiates which are the most prominent Pain management drug in the market in key producing countries such as Afghanistan and Myanmar. Paracetamol was recommended for use by various healthcare authorities across the world, to manage fever and mild pain in adults and children with COVID-19, which boosted the demand for the drug. Moreover, India and China being the chief API suppliers for Paracetamol drugs were unable to supply the APIs due to restrictions imposed due to COVID -19 which led to manufacturing restraints and shortages in many European countries.

Scope of the Report

  • The report presents insights on the 28 major drug development pipelines for Pain Management.
  • The report presents the analysis of the Pain Management Drugs Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
  • The report analyses the Pain Management Drugs Market by Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics, Others).
  • The report analyses the Pain Management Drugs Market by Route of Administration (Topical, Intravenous, Oral, Others).
  • The report analyses the Pain Management Drugs Market by End-use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain).
  • The report analyses the Pain Management Drugs Market by Availability (Over the Counter (OTC), Prescription).
  • The report analyses the Pain Management Drugs Market by Sales Channel (Retail Pharmacies, Hospital Pharmacies and E-commerce).
  • The Global Pain Management Drugs Market has been analysed By Region (Americas, Europe, Asia Pacific, and MEA).
  • The Global Pain Management Drugs Market has been analysed By Country (United States, Canada, Germany, U.K, France, Spain, Italy, China, Japan and India).
  • The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Drug Class, by Indication, by End User, by Formulation, and by Distribution Channel.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Pfizer, Johnson and Johnson, GSK Plc., Bristol-Myers Squibb, AbbVie, Bayer, Boehringer Ingelheim, Novartis, Teva Pharmaceutical, Sanofi, Amgen.

Key Target Audience

  • Pain Management Drugs Companies
  • Healthcare and Pharmaceutical Companies
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities
  • Investment Banks and Equity Firms

Table of Contents

1. Report Scope and Methodology

  • 1.1 Scope of the Report
  • 1.2 Research Methodology
  • 1.3 Executive Summary

2. Strategic Recommendations

3. Global Pain Management Drugs Market: Product Overview

4. Global Pain Management Drugs Market: Pipeline Analysis

  • 4.1. Competitive Positioning of Prominent companies with Pain management Drugs in their Pipeline
  • 4.2 Investigational New Drug
    • 4.2.1 Basimglurant (NOE-101), Drug Description and Outcomes
  • 4.3 Phase I
    • 4.3.1 Resiniferatoxin (RTX), Drug Description and Outcomes
    • 4.3.2 VX-548, Drug Description and Outcomes
  • 4.4 Phase - II/III
    • 4.4.1 TLC590, Bupivacaine, Drug Description and Outcomes
  • 4.5 Phase II
    • 4.5.1 BAY2395840, Drug Description and Outcomes
    • 4.5.2 Libvatrep- SAF312, Drug Description and Outcomes
    • 4.5.3 Trametinib, Drug Description and Outcomes
    • 4.5.4 Canakinumab + LNA043, Drug Description and Outcomes
    • 4.5.5 Erenumab-aooe (EREN), Drug Description and Outcomes
    • 4.5.6 Erenumab-Aooe (AimovigÆ), Drug Description and Outcomes
    • 4.5.7 Erenumab-Aooe 70 MG, Drug Description and Outcomes
    • 4.5.8 BOTOX (onabotulinumtoxinA) , Drug Description and Outcomes
    • 4.5.9 Resiniferatoxin, Drug Description and Outcomes
    • 4.5.10 Resiniferatoxin, Zilretta, Drug Description and Outcomes
    • 4.5.11 LY3526318, Drug Description and Outcomes
    • 4.5.12 LY3526318, Drug Description and Outcomes
    • 4.5.13 Quinagolide (FE 999051), Drug Description and Outcomes
    • 4.5.14 HMI-115, Drug Description and Outcomes
  • 4.6 Phase III
    • 4.6.1 Secukinumab, Drug Description and Outcomes
    • 4.6.2 Venglustat (GZ402671) , Drug Description and Outcomes
    • 4.6.3 Elagolix + Estradiol/Norethindrone Acetate, Drug Description and Outcomes
    • 4.6.4 Elagolix + Combined Oral Contraceptive (COC), Drug Description and Outcomes
    • 4.6.5 Ibuprofen PR (300 mg and 200 mg), Drug Description and Outcomes
    • 4.6.6 Ibuprofen Liquid Capsules (200 mg), Drug Description and Outcomes
    • 4.6.7 Intravenous (IV) tramadol (AVE-901), Drug Description and Outcomes
  • 4.7 Phase IV
    • 4.7.1 Catapresan, Drug Description and Outcomes
    • 4.7.2 Ubrogepant 50 MG, 100MG, Drug Description and Outcomes Galcanezumab, Drug Description and Outcomes Erenumab Prefilled Syringe, Drug Description and Outcomes

5. Global Pain Management Drugs Market: An Analysis

  • 5.1. Assessment of Macro-Economic Indicators of Global Pain Management Drugs Market
  • 5.2. Pain Management Drugs Market
  • 5.3 Market Size, By Value, 2018-2028
  • 5.4 Global Pain Management Drugs Market: Growth and Forecast
  • 5.5 Impact of COVID-19 on Global Pain Management Drugs Market

6. Global Pain Management Drugs Market: Segment Analysis By Drug Type

  • 6.1 Global Pain Management Drugs Market Segmentation, By Drug Type
  • 6.2 Competitive Positioning of Pain Management Drugs Market: By Drug Type (2021 & 2028)
  • 6.3 By Acetaminophen, By Value (USD Million), 2018-2028
  • 6.4 By NSAIDs, By Value (USD Million), 2018-2028
  • 6.5 By Narcotics (opioids), By Value (USD Million), 2018-2028
  • 6.6 By Others, By Value (USD Million), 2018-2028

7. Global Pain Management Drugs Market: Segment Analysis By Route of Administration

  • 7.1 Global Pain Management Drugs Market Segmentation, By Route of Administration
  • 7.2 Competitive Positioning of Pain Management Drugs Market: By Route of Administration (2021 & 2028)
  • 7.3 By Topical, By Value (USD Million), 2018-2028
  • 7.4 By Intravenous, By Value (USD Million), 2018-2028
  • 7.5 By Oral, By Value (USD Million), 2018-2028
  • 7.6 By Others, By Value (USD Million), 2018-2028

8. Global Pain Management Drugs Market: Segment Analysis By End Use

  • 8.1 Global Pain Management Drugs Market Segmentation, By End Use
  • 8.2 Competitive Positioning of Pain Management Drugs Market: By End Use (2021 & 2028)
  • 8.3 By Inflammation, By Value (USD Million), 2018-2028
  • 8.4 By Neuropathic Pain, By Value (USD Million), 2018-2028
  • 8.5 By Musculoskeletal Pain, By Value (USD Million), 2018-2028
  • 8.6 By Severe and Chronic Pain, By Value (USD Million), 2018-2028

9. Global Pain Management Drugs Market: Segment Analysis By Availability

  • 9.1 Global Pain Management Drugs Market Segmentation, By Availability
  • 9.2 Competitive Positioning of Pain Management Drugs Market: By Availability (2021 & 2028)
  • 9.3 By Prescription, By Value (USD Million), 2018-2028
  • 9.4 By Over The Counter (OTC), By Value (USD Million), 2018-2028

10. Global Pain Management Drugs Market: Segment Analysis

  • 10.1 Global Pain Management Drugs Market Segmentation, By Sales Channel
  • 10.2 Competitive Positioning of Pain Management Drugs Market: By Sales Channel (2021 & 2028)
  • 10.3 By Hospital Pharmacies, By Value (USD Million), 2018-2028
  • 10.4 By Retail Pharmacies, By Value (USD Million), 2018-2028
  • 10.5 By E-commerce, By Value (USD Million), 2018-2028

11. Global Pain Management Drugs Market: Regional Analysis

  • 11.1 Competitive Positioning of Global Pain Management Drugs Market: By Region (2021 & 2028)

12. Americas Pain Management Drugs Market: An Analysis (2018-2028)

  • 12.1 Assessment of Macro-Economic Indicators of Americas Pain Management Drugs Market
  • 12.2 Americas Pain Management Drugs Market- Size and Forecast, By Value (2018-2028)
  • 12.3 Americas Pain Management Drugs Market
  • 12.4 Americas Pain Management Drugs Market: Prominent Companies
  • 12.5 Americas Pain Management Drugs Market: Segment Analysis
  • 12.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value
  • 12.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
  • 12.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
  • 12.9 Market Segmentation By Availability (OTC, Prescription), By Value
  • 12.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
  • 12.13 Americas Pain Management Drugs Market: Country Analysis
  • 12.14 Market Opportunity Chart of Americas Pain Management Drugs Market - By Country, By Value (Year-2028)
  • 12.15 Competitive Positioning of Americas Pain Management Drugs Market - By Country
  • 12.16 United States Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 12.17 United States Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration, By End use, By Availability By Sales Channel (2018-2028)
  • 12.18 Canada Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 12.19 Canada Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

13. Europe Pain Management Drugs Market: An Analysis (2018-2028)

  • 13.1 Assessment of Macro-Economic Indicators of Europe Pain Management Drugs Market
  • 13.2 Europe Pain Management Drugs Market By value: Size and Forecast (2018-2028)
  • 13.3 Europe Pain Management Drugs Market
  • 13.4 Europe Pain Management Drugs Market: Prominent Companies
  • 13.5 Europe Pain Management Drugs Market: Segment Analysis
  • 13.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value
  • 13.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
  • 13.4 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
  • 13.5 Market Segmentation By Availability (OTC, Prescription), By Value
  • 13.6 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
  • 13.7 Europe Pain Management Drugs Market: Country Analysis
  • 13.8 Market Opportunity Chart of Europe Pain Management Drugs Market - By Country, By Value (Year-2028)
  • 13.9 Competitive Positioning of Europe Pain Management Drugs Market - By Country
  • 13.10 Germany Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 13.11 Germany Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
  • 13.12 United Kingdom Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 13.13 United Kingdom Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
  • 13.14 France Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 13.15 France Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
  • 13.16 Spain Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 13.17 Spain Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
  • 13.18 Italy Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 13.19 Italy Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

14 APAC Pain Management Drugs Market: An Analysis (2018-2028)

  • 14.1 Assessment of Macro-Economic Indicators of APAC Pain Management Drugs Market
  • 14.2 APAC Pain Management Drugs Market By value: Size and Forecast (2018-2028)
  • 14.3 APAC Pain Management Drugs Market
  • 14.4 APAC Pain Management Drugs Market: Prominent Companies
  • 14.5 APAC Pain Management Drugs Market: Segment Analysis
  • 14.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value
  • 14.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
  • 14.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
  • 14.9 Market Segmentation By Availability (OTC, Prescription), By Value
  • 14.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
  • 14.11 APAC Pain Management Drugs Market: Country Analysis
  • 14.12 Market Opportunity Chart of APAC Pain Management Drugs Market - By Country, By Value (Year-2028)
  • 14.13 Competitive Positioning of APAC Pain Management Drugs Market - By Country
  • 14.14 China Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 14.15 China Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
  • 14.16 Japan Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 14.7 Japan Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
  • 14.8 India Pain Management Drugs Market: Size and Forecast (2018-2028)
  • 14.9 India Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

15. Middle East and Africa Pain Management Drugs Market

  • 15.1 Assessment of Macro-Economic Indicators of MEA Pain Management Drugs Market
  • 15.2 Middle East and Africa Pain Management Drugs Market By value: Size and Forecast (2018-2028)
  • 15.3 Market Segmentation By Drug Type (Antibiotics, Antifungals, Astringents, Antipruritic, Analgesics, Others)
  • 15.4 Market Segmentation By Route of Administration (Skin Disease, Pain Management, Eye and Ear Care, Others), By Value
  • 15.5 Market Segmentation By End use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Others), By Value
  • 15.6 Market Segmentation By Availability (Prescription, Over The Counter (OTC), Others), By Value
  • 15.7 Market Segmentation By Sales Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Value

16. Global Pain Management Drugs Market Dynamics

  • 16.1 Global Pain Management Drugs Market Drivers
  • 16.2 Global Pain Management Drugs Market Restraints
  • 16.3 Global Pain Management Drugs Market Trends

17. Market Attractiveness and Strategic Analysis

  • 17.1 Market Attractiveness Chart of Global Pain Management Drugs Market - By Drug Type (2028)
  • 17.2 Market Attractiveness Chart of Global Pain Management Drugs Market - By Route of Administration (2028)
  • 17.3 Market Attractiveness Chart of Global Pain Management Drugs Market - By End-use (2028)
  • 17.4 Market Attractiveness Chart of Global Pain Management Drugs Market - By Availability (2028)
  • 17.5 Market Attractiveness Chart of Global Pain Management Drugs Market - By Sales Channel (2028)

17,6 Market Attractiveness Chart of Global Pain Management Drugs Market - By Region (2028)

18. Competitive Landscape

  • 18.1 Market Share of global leading companies

19. Company Profiles (Business Description, Financial Analysis, Business Strategy)

  • 19.1 Pfizer Inc.
  • 19.2 Johnson & Johnson
  • 19.3 GSK plc.
  • 19.4 Bristol-Myers Squibb Company
  • 19.5 Bayer AG
  • 19.6 Boehringer Ingelheim
  • 19.7 AbbVie Inc.
  • 19.8 Teva pharmaceuticals
  • 19.9 Sanofi
  • 19.10 Amgen

List of Figures

List of Figures

  • Figure 1: Global Urban Population (2016-2020) (% of total)
  • Figure 2: Global Aged Population (Above 65), 2015-20 (% of total Population)
  • Figure 3: Global Aged Population(Above 65), By Country, 2020 (% of total Population)
  • Figure 4: Global Medical Spending in 2020, By Region, (% of Total)
  • Figure 5: Total number of hospitals in select countries worldwide in 2019-20
  • Figure 6: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2016-2020 (In %)
  • Figure 7: Estimated global prevalence and numbers of adults living with obesity (Obesity (Class I, II and III) BMI =30kg/m2 in 2010 -2030
  • Figure 8: Age-adjusted comparative prevalence of diabetes, % (2000-2045)
  • Figure 9: Global Expected Healthcare Industry Outlook
  • Figure 10: Regional Expected Healthcare Industry Growth Rate By Year 2024
  • Figure 11: Global Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 12: Global Estimated number of Cancer Types with high prevalence of pain (incidences and prevalent cases)(all ages, in millions), Year 2019
  • Figure 13: Global Incidence of Road injuries,(in Millions), 2019
  • Figure 14: Incidence of Injury from Fire, heat, and hot substances (In million), Year 2019
  • Figure 15: Global Pain Management Drugs Market- By Drug Type , Market Share, 2021 & 2028
  • Figure 16: Global Pain Management Drugs Market- By Drug Type , By Acetaminophen (USD Million), 2018-2028
  • Figure 17: Global Pain Management Drugs Market- By Drug Type , By NSAIDs, By Value (USD Billion), 2018-2028
  • Figure 18: Global Pain Management Drugs Market- By Drug Type , By Narcotics (opioids), By Value (USD Billion), 2018-2028
  • Figure 19: Global Pain Management Drugs Market- By Drug Type , By Others , By Value (USD Billion), 2018-2028
  • Figure 20: Global Pain Management Drugs Market- By Route of Administration Market Share, 2021 & 2028
  • Figure 21: Global Pain Management Drugs Market- By Route of Administration , By Topical Route (USD Billion), 2018-2028
  • Figure 22: Global Pain Management Drugs Market- By Route of Administration , By Intravenous Route (USD Billion), 2018-2028
  • Figure 23: Global Pain Management Drugs Market- By Route of Administration , By Oral Route (USD Billion), 2018-2028
  • Figure 24: Global Pain Management Drugs Market- By Route of Administration , By Others (USD Billion), 2018-2028
  • Figure 25: Global Pain Management Drugs Market- By End use, Market Share, 2021 & 2028
  • Figure 26: Global Pain Management Drugs Market- By End use, By Inflammation, By Value (USD Billion), 2018-2028
  • Figure 27: Global Pain Management Drugs Market- By End use, By Neuropathic Pain, By Value (USD Billion), 2018-2028
  • Figure 28: Global Pain Management Drugs Market- By End use, By Musculoskeletal Pain, By Value (USD Billion), 2018-2028
  • Figure 29: Global Pain Management Drugs Market- By End use, By Severe and Chronic Pain, By Value (USD Billion), 2018-2028
  • Figure 30: Global Pain Management Drugs Market- By Availability Market Share, 2021 & 2028
  • Figure 31: Global Pain Management Drugs Market- By Availability, By Prescription (USD Billion), 2018-2028
  • Figure 32: Global Pain Management Drugs Market- By Availability, By Over The Counter (OTC), By Value (USD Billion), 2018-2028
  • Figure 33: Global Pain Management Drugs Market- By Sales Channel Market Share, 2021 & 2028
  • Figure 34: Global Pain Management Drugs Market- By Sales Channel, By Hospital Pharmacies, By Value (USD Billion), 2018-2028
  • Figure 35: Global Pain Management Drugs Market- By Sales Channel, By Retail Pharmacies, By Value (USD Billion), 2018-2028
  • Figure 36: Global Pain Management Drugs Market- By Sales Channel, By E-commerce , By Value (USD Billion), 2018-2028
  • Figure 37: Global Pain Management Drugs Market- By Region Market Share, 2021 & 2028
  • Figure 38: North America Population (in Millions), 2018-2021
  • Figure 39: North America Population ages 65 and above (% of total Population), 2016-2020
  • Figure 40: North America Current health expenditure per capita (current USD), 2015-19
  • Figure 41: Latin America Population (in Millions), 2018-2021
  • Figure 42: Incidence of Cancer in North and South America, (in million), 2020
  • Figure 43: Incidence of Road injuries in Region of the Americas, (in million), 2016-2019
  • Figure 44: Incidence of injuries from Fire, heat, and hot substances in Region of Americas, 2016-2019, (in millions)
  • Figure 45: Prevalence of Osteoarthritis in Region of Americas, 2015-2019, (in millions)
  • Figure 46: Prevalence of Diabetes in Regions of America, (in million), 2021
  • Figure 47: Incidence of Appendicitis in Region of the Americas, (in million), 2016-2019
  • Figure 48: Prevalence of chronic Low back and Neck Pain in Region of Americas, 2016-2019, (in millions)
  • Figure 49: Americas Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 50: Americas Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 51: Americas Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 52: Americas Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 53: Americas Pain Management Drugs Market- By Availability , By Value (USD Billion), 2018-2028
  • Figure 54: Americas Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 55: Market Opportunity Chart of Americas Pain Management Drugs Market- By Country, By Value (Year-2028)
  • Figure 56: Americas Pain Management Drugs Market- By Country Market Share, 2021 & 2028
  • Figure 57: United States Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 58: United States Pain Management Drugs Market- By Drug Type , By Value (USD Million), 2018-2028
  • Figure 59: United States Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 60: United States Pain Management Drugs Market- By End use, By Value (USD Million), 2018-2028
  • Figure 61: United States Pain Management Drugs Market- By Availability , By Value (USD Million), 2018-2028
  • Figure 62: United States Pain Management Drugs Market- By Sales Channel, By Value (USD Million), 2018-2028
  • Figure 63: Canada Pain Management Drugs Market Size, By Value, 2018-2028 (USD Million)
  • Figure 64: Canada Pain Management Drugs Market- By Drug Type , By Value (USD Million), 2018-2028
  • Figure 65: Canada Pain Management Drugs Market- By Route of Administration , By Value (USD Million), 2018-2028
  • Figure 66: Canada Pain Management Drugs Market- By End use, By Value (USD Million), 2018-2028
  • Figure 67 : Canada Pain Management Drugs Market- By Availability , By Value (USD Million), 2018-2028
  • Figure 68: Canada Pain Management Drugs Market- By Sales Channel, By Value (USD Million), 2018-2028
  • Figure 69: European Union Population (in Millions), 2017-2020
  • Figure 70: Population ages 65 and above (% of total Population) in European Countries, 2020
  • Figure 71: European Union Current health expenditure per capita (current USD), 2015-19
  • Figure 72: Total expenditure on health per capita in European countries (in USD PPP), 2019
  • Figure 73: Incidence of Cancer in Europe, (in million), 2016-2019
  • Figure 74: Incidence of Road Injuries in Europe , 2016-2019 (In Million)
  • Figure 75: Incidence of Injuries from Fire, heat, and hot substances in Europe (all ages, in Million), Year 2016-2019
  • Figure 76: Prevalence of Osteoarthritis Diseases in Europe, (in Million), 2015-2019
  • Figure 77: Estimated Prevalence of Diabetes in Europe, (in million), 2011, 2021, 2030(E),2045(E)
  • Figure 78: Incidence of Appendicitis in Europe, (in million), 2016-2019
  • Figure 79: Prevalence of chronic Low back and Neck Pain in Europe, 2016-2019, (in millions)
  • Figure 80: Europe Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 81: Europe Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 82: Europe Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 83: Europe Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 84: Europe Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 85: Europe Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 86: Market Opportunity Chart of Europe Pain Management Drugs Market- By Country, By Value (Year-2028)
  • Figure 87: Europe Pain Management Drugs Market- By Country Market Share, 2021 & 2028
  • Figure 88: Germany Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 89: Germany Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 90: Germany Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 91: Germany Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 92: Germany Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 93: Germany Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 94: United Kingdom Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 95: United Kingdom Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 96: United Kingdom Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 97: United kingdom Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 98: United Kingdom Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 99: United Kingdom Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 100: France Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 101: France Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 102: France Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 103: France Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 104: France Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 105: France Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 106: Spain Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 107: Spain Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 108: Spain Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 109: Spain Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 110: Spain Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 111: Spain Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 112: Italy Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 113: Italy Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 114: Italy Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 115: Italy Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 116: Italy Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 117: Italy Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 118: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
  • Figure 119: Asia Pacific Population ages 65 and above, By Countries (% of total Population), 2020
  • Figure 120: Asia Pacific Current health expenditure per capita (current USD), 2014-18
  • Figure 121: Asia Pacific, Current health expenditure per capita, By countries (current USD), 2019
  • Figure 122: East Asia and Pacific Population (in Billion), 2018-2020
  • Figure 123: Prevalence of Osteoarthritis Diseases in Asia Pacific, (in million), 2015-2019
  • Figure 124: Incidence of Cancer in Asia, By countries (in million), 2020
  • Figure 125: Incidence of Road Injuries in Asia , 2016-2019 (In Million)
  • Figure 126: Estimated Prevalence of Diabetes in South-East Asia, (in million), 2011, 2021, 2030(E),2045(E)
  • Figure 127: Incidence of Appendicitis in Asia, (in million), 2016-2019
  • Figure 128: Prevalence of chronic Low back and Neck Pain in Europe, 2016-2019, (in millions)
  • Figure 129: Incidence of Injuries from Fire, heat, and hot substances in Asia (all ages, in Million), Year 2016-2019
  • Figure 130: Asia Pacific Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 131: Asia Pacific Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 132 Asia Pacific Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 133 Asia Pacific Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 134 Asia Pacific Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 135 Asia Pacific Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 136 Market Opportunity Chart of APAC Pain Management Drugs Market- By Country, By Value (Year-2028)
  • Figure 137 APAC Pain Management Drugs Market- By Country Market Share, 2021 & 2028
  • Figure 138 China Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 139 China Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 140 China Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 141 China Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 142: China Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 143: China Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 144: Japan Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 145: Japan Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 146: Japan Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 147: Japan Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 148: Japan Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 149: Japan Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 150: India Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 151: India Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 152: India Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 153: India Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 154: India Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 155: India Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 156: Middle East and North Africa Population(in Million), 2018-2020
  • Figure 157: Middle East and North Africa, GDP Per Capita, value (USD Million), 2018-2020
  • Figure 158: Middle East and North Africa, Population ages 65 and above (% of total population), 2016-19
  • Figure 159: Middle East and North Africa, Incidence of Osteoarthritis (in millions), 2016-19
  • Figure 160: Incidence of Cancer in AFRO, By countries (ASR per 100,000), 2020
  • Figure 161: Incidence of Injuries from Fire, heat, and hot substances in North Africa and Middle East (all ages, in Million), Year 2016-2019
  • Figure 162: Incidence of Road Injuries in North Africa and Middle East , 2016-2019 (In Million)
  • Figure 163: Estimated Prevalence of Diabetes in Middle East and North Africa, (in million), 2011, 2021, 2030(E),2045(E)
  • Figure 164: Incidence of Appendicitis in North Africa and Middle East , (in thousands), 2016-2019
  • Figure 165: Prevalence of chronic Low back and Neck Pain in North Africa and Middle East , 2016-2019, (in millions)
  • Figure 166: Middle East and Africa Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
  • Figure 167: Middle East and Africa Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
  • Figure 168: Middle East and Africa Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
  • Figure 169: Middle East and Africa Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
  • Figure 170: Middle East and Africa Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
  • Figure 171: Middle East and Africa Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
  • Figure 172: Market Attractiveness Chart of Global Pain Management Drugs Market- By Drug Type (Year-2028)
  • Figure 173: Market Attractiveness Chart of Global Pain Management Drugs Market- By Route of Administration (Year-2028)
  • Figure 174: Market Attractiveness Chart of Global Pain Management Drugs Market- By End use (Year-2028)
  • Figure 175: Market Attractiveness Chart of Global Pain Management Drugs Market- By Availability (Year-2028)
  • Figure 176: Market Attractiveness Chart of Global Pain Management Drugs Market- By Sales Channel (Year-2028)
  • Figure 177: Market Attractiveness Chart of Global Pain Management Drugs Market- By Region (Year-2028)
  • Figure 178: Global Pain Management Drugs Market Share (%), 2021
  • Figure 179: PFIZER Inc. Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 180: PFIZER Inc. Net Income, 2017-2021 (USD Million)
  • Figure 181: Pfizer Inc. Sales Revenue, By Business Segment (%), FY2021
  • Figure 182: Pfizer Inc. Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 183: Johnson and Johnson Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 184: Johnson and Johnson Net Income, 2017-2021 (USD Million)
  • Figure 185: Johnson and Johnson Sales Revenue, By Business Segment (%), FY2021
  • Figure 186: Johnson and Johnson Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 187: GSK plc. Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 188: GSK plc. Net Income, 2017-2021 (USD Million)
  • Figure 189: GSK plc. Sales Revenue, By Business Segment (%), FY2021
  • Figure 190: GSK plc. Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 191: Bristol-Myers Squibb Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 192: Bristol-Myers Squibb Net Income, 2017-2021 (USD Million)
  • Figure 193: Bristol-Myers Squibb Sales Revenue, By Geographical Segment (%), FY2020
  • Figure 194: Bristol-Myers Squibb Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 195: Bayer Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 196: Bayer Net Income, 2017-2021 (USD Million)
  • Figure 197: Bayer Sales Revenue, By Business Segment (%), FY2021
  • Figure 198: Bayer Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 199: Boehringer Ingelheim Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 200: Boehringer Ingelheim Net Income, 2017-2021 (USD Million)
  • Figure 201: Boehringer Ingelheim Sales Revenue, By Business Segment (%), FY2021
  • Figure 202: Boehringer Ingelheim Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 203: AbbVie Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 204: AbbVie Net Income, 2017-2021 (USD Million)
  • Figure 205: AbbVie Sales Revenue, By Business Segment (%), FY2021
  • Figure 206: AbbVie Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 207: Teva Pharmaceuticals Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 208: Teva Pharmaceuticals Net Income, 2017-2021 (USD Million)
  • Figure 209: Teva Pharmaceuticals Sales Revenue, By Operating Segment (%), FY2020
  • Figure 210: Teva Pharmaceuticals Sales Revenue, By Operating Segment (%), FY2021
  • Figure 211: Sanofi Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 212: Sanofi Pharmaceuticals Net Income, 2017-2021 (USD Million)
  • Figure 213: Sanofi Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 214: Sanofi Sales Revenue, By Business Segment (%), FY2021
  • Figure 215: Amgen Annual Sales Revenue, 2017-2021 (USD Million)
  • Figure 216: Amgen Pharmaceuticals Net Income, 2017-2021 (USD Million)
  • Figure 215: Amgen Sales Revenue, By Geographical Segment (%), FY2021
  • Figure 216: Amgen Sales Revenue, By Products (%), FY2021